Mr Petros Charalampoudis
Breast Health
Profile Summary
Qualifications
MD PhD FRCSEng FEBS (Breast Surgery)
Special Interests
Oncoplastic breast surgery, Breast lumps, Breast Pain, Breast cancer, Breast reconstruction, Family history of breast cancer, Risk reducing breast surgery, Nipple discharge, Mammoplasty
Recognised by
Specialist Treatments
Treatments offered at King Edward VII's Hospital include, but are not limited to:
- Mastectomy
- Lumpectomy
- Wireless Image Guided Breast Conservation
- Implant Reconstruction
- Sentinel Node Biopsy
- Axillary Clearance
- Therapeutic Mammoplasty
My Practice
My ethos is pivoted around patient-centred care. Breast cancer is a long journey, which is why I believe it is crucial for patients to feel that they are in good hands and are being treated by a team with expertise and compassion.
Professional Biography
Mr Petros Charalampoudis is an expert Consultant Oncoplastic and Reconstructive Breast Surgeon at King Edward VII's Hospital. {{ label }}
He has particular interest in the treatment of breast cancer and benign (non-cancerous) breast conditions. He manages all aspects of breast disease and offers the latest evidence-based techniques and approaches in a tailored, individualised fashion.
Mr Charalampoudis accrued over 15 years of experience in medical and surgical training before becoming a fine clinical consultant surgeon with a strong research and teaching portfolio. He holds a Medical Degree and a PhD in Breast Cancer from Athens University Medical School.
He has also completed a prestigious Oncoplastic and Reconstructive Breast Surgery Fellowship at Guy’s Hospital Breast Unit and King’s College London, where he was also appointed Consultant and Honorary Clinical Lecturer. He is a Fellow of the Royal College of Surgeons of England and Fellow of the European Board of Breast Surgery.
He collaborates with a fine team of Clinical Nurse Specialists, Radiologists, Pathologists, Oncologists and Plastic Surgeons, in order to offer his patients a truly individualised, teamed approach.
- Additional Information
-
COVID-19 Specific Projects / Groups
I worked as part of the North East Central London Breast Cancer Hub during the NHS COVID response.
Memberships
I am a member of the following:
- General Medical Council
- Specialist Register Fellow of the Royal College of Surgeons of England
- Fellow and Examiner, European Board of Breast Surgery
Training Positions
I am an Examiner and Trainer in Oncoplastic Breast Surgery for the European Board of Breast Surgery.
Cutting Edge Technologies
I have performed Magseed Localised Oncoplastic Breast Conservation.
Publications
I have published the following papers:
- Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction. Potter S, Trickey A, Rattay T, O’Connell RL, Dave R, Baker E, Whisker L, Skillman J, Gardiner MD, Macmillan RD, Holcombe C; TeaM and iBRA-2 Steering Groups, the Breast Reconstruction Research Collaborative, and the Mammary Fold Academic and Research Collaborative. Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19. PMID: 32073654.
- The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study. O’Connell RL, Rattay T, Dave RV, Trickey A, Skillman J, Barnes NLP, Gardiner M, Harnett A, Potter S, Holcombe C; iBRA-2 Steering Group; Breast Reconstruction Research Collaborative. Br J Cancer. 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29. PMID: 30923359 Free PMC article. Clinical Trial.
- Neoadjuvant chemotherapy for early breast cancer. Charalampoudis P, Karakatsanis A. Lancet Oncol. 2018 Mar;19(3):e128. doi: 10.1016/S1470-2045(18)30115-3. PMID: 29508753 No abstract available.
- The “Yin and Yang” of Platelet-rich Plasma in Breast Reconstruction After Mastectomy or Lumpectomy for Breast Cancer. Spartalis E, Tsilimigras DI, Charalampoudis P, Karachaliou GS, Moris D, Athanasiou A, Spartalis M, Bolkas V, Dimitroulis D, Nikiteas N. Anticancer Res. 2017 Dec;37(12):6557-6562. doi: 10.21873/anticanres.12112. PMID: 29187430 Review.
- Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data. Charalampoudis P, Markopoulos C, Kovacs T. Eur J Surg Oncol. 2018 Jan;44(1):5-14. doi: 10.1016/j.ejso.2017.10.215. Epub 2017 Nov 13. PMID: 29174281 Review.
- Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland. Tang SS, Kaptanis S, Haddow JB, Mondani G, Elsberger B, Tasoulis MK, Obondo C, Johns N, Ismail W, Syed A, Kissias P, Venn M, Sundaramoorthy S, Irwin G, Sami AS, Elfadl D, Baggaley A, Remoundos DD, Langlands F, Charalampoudis P, Barber Z, Hamilton-Burke WLS, Khan A, Sirianni C, Merker LAG, Saha S, Lane RA, Chopra S, Dupré S, Manning AT, St John ER, Musbahi A, Dlamini N, McArdle CL, Wright C, Murphy JO, Aggarwal R, Dordea M, Bosch K, Egbeare D, Osman H, Tayeh S, Razi F, Iqbal J, Ledwidge SFC, Albert V, Masannat Y. Eur J Cancer. 2017 Oct;84:315-324. doi: 10.1016/j.ejca.2017.07.032. Epub 2017 Aug 30. PMID: 28865259 Clinical Trial.
- High-intensity focused ultrasound in the treatment of breast fibroadenomata (HIFU-F trial). Peek MCL, Ahmed M, Scudder J, Baker R, Charalampoudis P, Pinder SE, Douek M; HIFU-F Collaborators. Int J Hyperthermia. 2018 Nov;34(7):1002-1009. doi: 10.1080/02656736.2017.1373865. Epub 2017 Oct 2. PMID: 28854826.
- Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis. Charalampoudis P, Agrogiannis G, Kontzoglou K, Kouraklis G, Sotiropoulos GC. Eur J Surg Oncol. 2017 Aug;43(8):1428-1432. doi: 10.1016/j.ejso.2017.05.012. Epub 2017 May 25. PMID: 28583788.
- Blue dye for identification of sentinel nodes in breast cancer and malignant melanoma: a systematic review and meta-analysis. Peek MC, Charalampoudis P, Anninga B, Baker R, Douek M. Future Oncol. 2017 Feb;13(5):455-467. doi: 10.2217/fon-2016-0255. Epub 2016 Aug 31. PMID: 27578614 Review.
- Incidence of inactive allele CYP2D6*4 among Greek women suffering from hormone-sensitive breast cancer. Kykalos S, Mantas D, Charalampoudis P, Kouraklis G, Markopoulos C. Eur J Gynaecol Oncol. 2016 Aug;37(4):504-510. PMID: 29894075.
- Surgery for liver metastases from breast cancer. Charalampoudis P, Mantas D, Sotiropoulos GC, Dimitroulis D, Kouraklis G, Markopoulos C. Future Oncol. 2015;11(10):1519-30. doi: 10.2217/fon.15.43. PMID: 25963429 Review.
I have also edited the book ‘Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook’, Editors: Wyld, L., Markopoulos, C., Leidenius, M., Senkus-Konefka, E. (Eds.).
Need some help?
Call 020 7467 4344